Southeast Asian Brugada Syndrome Group
Official title: Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population
Run by Chulalongkorn University · NCT04232787 · Data updated 2026-11-12
A group of Brugada syndrome patients in Thailand are being studied to see how genetic differences relate to their diagnosis and how severe their symptoms are.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 750 (estimated) |
| Sponsor | Chulalongkorn University Academic / other |
| Locations | 11 sites (Bangkok, Bangkok and 10 other locations) |
| Status | Recruiting |
| Started | January 28, 2016 |
| Main results expected | January 5, 2031 |
| Study ends | January 5, 2031 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT04232787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Thai individuals with confirmed Brugada type 1 ECG (on resting ECG or after provocative testing) who do not have other major cardiac diseases.
✕Probably not a fit
Individuals without Brugada type 1 ECG criteria or those with significant concurrent cardiac conditions may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort in Thailand collects demographic, clinical, ECG, and genetic data from Brugada syndrome patients and healthy controls. Researchers perform whole genome sequencing and SNP arrays to identify genetic variants, and then compare findings between cases and controls. Patients are followed over time to monitor symptoms and implantable cardioverter-defibrillator shocks, with analyses linking genetic variants to clinical severity. The study aims to clarify how genetics may influence BrS presentation and prognosis in Southeast Asian populations.
Why it matters
Potential benefit: Greater understanding of genetic factors could improve risk stratification and personalized management for Brugada syndrome patients.
How similar studies have gone: Previous research has linked genetic variation to BrS features, but this Southeast Asian cohort provides novel regional data that may strengthen or refine those associations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Thai nationality * The patient has at least one of confirmed Brugada type 1 ECG in at least one of right precordial leads (v1 or v2) with or without pharmacologic provocative testing. The confirmed ECG is standard 12 lead ECG or Brugada lead Exclusion Criteria: * The patient has other cardiac diseases such as ischemic heart disease, valvular heart disease, congenital heart disease, myocarditis and pericarditis * The patient has type 2 or type 3 Brugada ECG without type 1 ECG during pharmacologic provocative testing and/or Brugada lead * The patient had one time of Brugada type 1 ECG during drug use without reproducibility
Where it's running
-
Bangkok Hospital
Bangkok, Bangkok, Thailand Recruiting -
Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, Thailand Recruiting -
Vajira Hospital
Dusit, Bangkok, Thailand Recruiting -
Chulalongkorn University
Pathum Wan, Bangkok, Thailand Recruiting -
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Ratchathewi, Bangkok, Thailand Recruiting -
Bhumibol Adulyadej RTAF Hospital
Sai Mai, Bangkok, Thailand Recruiting
Show 5 more locations
-
Bumrungrad International Hospital
Vadhana, Bangkok, Thailand Recruiting -
Pacific Rim Electrophysiology Research Institute Data Coordinating Center
Vadhana, Bangkok, Thailand Recruiting -
Queen Sirikit Heart Center of the Northeast
Khon Kaen, Changwat Khon Kaen, Thailand Recruiting -
Central Chest Hospital
Nonthaburi, Changwat Nonthaburi, Thailand Recruiting -
Faculty of Medicine, Chiang Mai University
Chiang Mai, Chiang Mai, Thailand Recruiting
Study contacts
- Principal investigator: Apichai Khongphatthanayothin, MD — Chulalongkorn University
- Study coordinator: Apichai Khongphatthanayothin, MD
- Email: apichaik@yahoo.com
- Phone: 66891555545
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Characterizing and Ablating Heart Issues in Brugada Syndrome Patients
This study tests if a special heart procedure can help people with Brugada Syndrome who have had serious heart rhythm problems by using advanced mapping to find and treat the areas causing those issues.
-
Long-term outcomes for patients with cardiac arrhythmias
This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.
-
Registry for patients with Brugada Syndrome at UZ Brussel
This study is collecting information from patients with Brugada syndrome at UZ Brussel to better understand the condition and how it affects them and their families.
-
Using cheek (buccal) cells to detect cell-junction protein changes in inherited arrhythmias
This project will test whether a painless cheek-swab can reveal the same heart cell-junction protein changes in people with inherited arrhythmias such as arrhythmogenic cardiomyopathy, Brugada syndrome, and other channelopathies.
-
Monitoring fetal heart activity in high-risk pregnancies to prevent stillbirth
This study is testing a new way to monitor fetal heart activity in high-risk pregnancies to see if it can help prevent stillbirth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.